Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 5
Submit an article Journal homepage
47
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Specifically Targeting the CD22 Receptor of Human B-cell Lymphomas with RNA Damaging Agents: A New Generation of Therapeutics

Miriam Hursey Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201, USA
,
Dianne L. Newton SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201, USA
,
Hans J. Hansen Immunomedics Inc., Morris Plains, NJ 07950, USA
,
Dale Ruby SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201, USA
,
David M. Goldenberg Garden State Cancer Canter, Belleville, NJ 07109, USA
&
Susanna M. Rybak Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201, USA
Pages 953-959 | Published online: 23 May 2011

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michael J Brumlik, Benjamin J Daniel, Reinhard Waehler, David T Curiel, Francis J Giles & Tyler J Curiel. (2008) Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Expert Opinion on Drug Delivery 5:1, pages 87-103.
Read now

Articles from other publishers (28)

Barlas Büyüktimkin, John StewartJr.Jr., Kayann Tabanor, Paul Kiptoo & Teruna J. Siahaan. 2016. Drug Delivery. Drug Delivery 475 502 .
Binsah George, Hagop Kantarjian, Elias Jabbour & Nitin Jain. (2016) Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia. Immunotherapy 8:2, pages 135-143.
Crossref
Wojciech Ardelt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals 337 353 .
Mi-Ae Lyu, Yu (Joshua) Cao, Khalid A. Mohamedali & Michael G. Rosenblum. 2012. Protein Engineering for Therapeutics, Part A. Protein Engineering for Therapeutics, Part A 167 214 .
Carima Andrady, Surinder K Sharma & Kerry A Chester. (2011) Antibody–enzyme fusion proteins for cancer therapy. Immunotherapy 3:2, pages 193-211.
Crossref
Francisco J. Hernandez-Ilizaliturri & Myron S. Czuczman. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 338 366 .
Serengulam V. Govindan & David M. Goldenberg. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 371 392 .
Jean-Philippe Stephan, Pamela Chan, Chien Lee, Christopher Nelson, James Michael Elliott, Charity Bechtel, Helga Raab, David Xie, Jon Akutagawa, Jakub Baudys, Ola Saad, Saileta Prabhu, Wai Lee T. Wong, Richard Vandlen, Fred Jacobson & Allen Ebens. (2008) Anti-CD22-MCC-DM1 and MC-MMAF Conjugates: Impact of Assay Format on Pharmacokinetic Parameters Determination. Bioconjugate Chemistry 19:8, pages 1673-1683.
Crossref
Peter Martin, Richard R. Furman, Morton Coleman & John P. Leonard. (2007) Phase I to III Trials of Anti–B Cell Therapy in Non–Hodgkin's Lymphoma. Clinical Cancer Research 13:18, pages 5636s-5642s.
Crossref
Ira PastanRaffit HassanDavid J. FitzGeraldRobert J. Kreitman. (2007) Immunotoxin Treatment of Cancer. Annual Review of Medicine 58:1, pages 221-237.
Crossref
Robert J. Kreitman. (2006) Immunotoxins for targeted cancer therapy. The AAPS Journal 8:3, pages E532-E551.
Crossref
Franziska Leich, Jens Köditz, Renate Ulbrich-Hofman & Ulrich Arnold. (2006) Tandemization Endows Bovine Pancreatic Ribonuclease with Cytotoxic Activity. Journal of Molecular Biology 358:5, pages 1305-1313.
Crossref
Serengulam V. Govindan, Gary L. Griffiths, Hans J. Hansen, Ivan D. Horak & David M. Goldenberg. (2016) Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies. Technology in Cancer Research & Treatment 4:4, pages 375-391.
Crossref
Jürgen Krauss, Michaela A.E. Arndt, Bang K. Vu, Dianne L. Newton, Siegfried Seeber & Susanna M. Rybak. (2005) Efficient killing of CD22+ tumor cells by a humanized diabody–RNase fusion protein. Biochemical and Biophysical Research Communications 331:2, pages 595-602.
Crossref
Michaela A. E Arndt, Jürgen Krauss, Bang K Vu, Dianne L Newton & Susanna M Rybak. (2005) A Dimeric Angiogenin Immunofusion Protein Mediates Selective Toxicity Toward CD22+ Tumor Cells. Journal of Immunotherapy 28:3, pages 245-251.
Crossref
P. V. Zelenikhin, A. I. Kolpakov, G. V. Cherepnev & O. I. Ilinskaya. (2005) Induction of Apoptosis in Tumor Cells by Binase. Molecular Biology 39:3, pages 404-409.
Crossref
Jurgen Krauss, Michaela A.E. Arndt, Bang K. Vu, Dianne L. Newton & Susanna M. Rybak. (2005) Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme. British Journal of Haematology 128:5, pages 602-609.
Crossref
O. N. Ilinskaya & A. A. Makarov. (2005) Why ribonucleases induce tumor cell death. Molecular Biology 39:1, pages 1-10.
Crossref
John F. DiJoseph, Andrew Popplewell, Simon Tickle, Heather Ladyman, Alastair Lawson, Arthur Kunz, Kiran Khandke, Douglas C. Armellino, Erwin R. Boghaert, Philip R. Hamann, Karen Zinkewich-Peotti, Sue Stephens, Neil Weir & Nitin K. Damle. (2004) Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22. Cancer Immunology, Immunotherapy 54:1, pages 11-24.
Crossref
Richard R. Furman, Morton Coleman & John P. Leonard. (2004) Epratuzumab in non-hodgkin’ lymphomas. Current Treatment Options in Oncology 5:4, pages 283-288.
Crossref
J Krauss, M A E Arndt, Z Zhu, D L Newton, B K Vu, V Choudhry, R Darbha, X Ji, N S Courtenay-Luck, M P Deonarain, J Richards & S M Rybak. (2004) Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme. British Journal of Cancer 90:9, pages 1863-1870.
Crossref
John F. DiJosephDouglas C. ArmellinoErwin R. BoghaertKiran KhandkeMaureen M. DougherLatha SridharanArthur KunzPhilip R. HamannBoris GorovitsChandrasekhar UdataJustin K. MoranAndrew G. PopplewellSue StephensPhilip FrostNitin K. Damle. (2004) Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies. Blood 103:5, pages 1807-1814.
Crossref
Yaroslav I Tsybovsky, Alexey A Kedrov & Sergey P Martsev. (2004) Independent folding and conformational changes of the barnase module in the VL-barnase immunofusion: calorimetric evidence. FEBS Letters 557:1-3, pages 248-252.
Crossref
Michael Rosenblum. 2004. Treatment of Leukemia and Lymphoma. Treatment of Leukemia and Lymphoma 209 228 .
Leonard Presta. (2003) Antibody engineering for therapeutics. Current Opinion in Structural Biology 13:4, pages 519-525.
Crossref
Abby B. Siegel, David M. Goldenberg, Alessandra Cesano, Morton Coleman & John P. Leonard. (2003) CD22-directed monoclonal antibody therapy for lymphoma. Seminars in Oncology 30:4, pages 457-464.
Crossref
Alexander A Makarov & Olga N Ilinskaya. (2003) Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Letters 540:1-3, pages 15-20.
Crossref
Susanna M. Rybak, Michaela Arndt, Juergen Krauss, Dianne L. Newton, Bang K. Vu & Zhongyu Zhu. 2002. Biomedical Aspects of Drug Targeting. Biomedical Aspects of Drug Targeting 275 290 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.